Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.14 | N/A |
| PEG Ratio (TTM) | 2.90 | N/A |
| P/S Ratio (TTM) | 1.70 | N/A |
| P/B Ratio (TTM) | 0.97 | N/A |
| P/FCF Ratio (TTM) | 7.96 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.07 | N/A |
| Price to 5YR AVG FCF Ratio | 9.32 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.98% | N/A |
| ROE (TTM) | 10.15% | N/A |
| Net Profit Margin (TTM) | 16.75% | N/A |
| ROIC 5YR AVG | 12.92% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.50% | 171.47% | 103.03% |
| Revenue | 14.38% | 16.46% | 59,974.04% |
| Net Income | 3.91% | 162.98% | 97.19% |
| Cash Flow | 10.55% | 26.61% | 18.88% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.26 | N/A |
| Quick Ratio (TTM) | 0.26 | N/A |
| D/E Ratio (TTM) | 0.11 | N/A |
| Interest Coverage (TTM) | 1.42 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 1.08 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.70% | N/A |